INTRODUCTION
Cardiac rehabilitation, including exercise training to im prove exercise capacity and healthrelated quality of life (HRQoL) is recommended after heart transplant (HTx) [1] , but there are no clear and specific guidelines for how, how often or at what intensity exercise training should be performed.
Exercise capacity is often severely reduced shortly after HTx with peak oxygen consumption (VO2peak) levels reported to be between 9.2 and 19.7 mL/kg per min [212] . However, early measurement of VO2peak is not routine in most centers. VO2peak is the gold standard to objectively assess functional limitation and give an assessment of the integrative physiology involving cardiovascular, pul monary, muscular, cellular and oxidative systems [13, 14] . It has also been reported that VO2peak is a strong predictor for survival in HTx recipients [15, 16] . In studies of main tenance HTx patients, VO2peak seems to be determined by both central (chronotropic incompetence, reduced stroke volume and cardiac output, impaired systolic and diastolic function, pulmonary dysfunction) and peripheral factors (diminished skeletal muscular capacity) [1, 1719] . Other factors, like donor characteristics, diagnosis and deconditioning before transplantation may also be associated with reduced exercise capacity after HTx [18] . However, we have recently reported that the most important variables predicting VO2peak in maintenance HTx patients are mostly of peripheral origin [20, 21] . In de novo HTx patients, only two studies exist (n = 43 [6] and n = 24 [12] ), which report limiting factors for VO2peak. These studies indicate that both central and peripheral factors could be involved in the early phase, but the knowledge is scarce and thus, a better understanding of factors that are associated with peak exercise shortly after HTx could guide clinicians and physiotherapist for more individualized therapy and specific exercise recommendations.
We hypothesized that both central and peripheral factors are associated with reduced exercise capacity in de novo HTx recipients. In the present study, we performed cardiopulmonary exercise testing (CPET) in a cohort of de novo HTx patients with the aim to determine clinical, hemodynamic and peripheral factors that contribute to the reduced exercise capacity.
MATERIALS AND METHODS

Patients and settings
This study was conducted in three centers in Scandinavia (Oslo, Gothenburg and Copenhagen). Altogether, 155 de novo HTx patients were assessed for eligibility. Of these, 72 were excluded for various reasons: did not meet inclusion criteria (cognitive issues, physical disabilities, medical complications, language barriers, contagion, no physical therapist available) (n = 43); were not motivated (n = 15); logistic reasons (n = 14). In addition, two were excluded after they had given their consent, one due to medical complications and one withdrawal. A total of 81 patients underwent CPET. The study was approved by the SouthEast Regional Committee for medical and health research ethics in Norway and the Committee for medical and health research ethics in Sweden and Denmark. The study was conducted in accordance with the recommendations in the Helsinki Declaration.
The current study is based on the baseline data from an ongoing randomized controlled trial (RCT): The High intensity Interval Training in de novo heart Transplant recipients in Scandinavia (HITTS) study. The design and rationale of this study is described elsewhere [22] . In short, the RCT compares the effect of a 9mo long twoarmed intervention: Highintensity interval training versus mo derate intensity continuous training.
Inclusion criteria
The inclusion criteria were: Clinically stable HTx recipients approximately 812 wk after HTx; Age > 18 years; Both sexes; Receiving immunosuppressive therapy according to local protocols; Patient willing and able to give written informed consent for study participation, and motivated to participate in the study for nine months.
Measurements
The primary endpoint, VO2peak, was measured on a treadmill or a bicycle ergometer applying an indivi dualized protocol with an incremental workload until exhaustion [23] . The Norwegian populations were tested on a treadmill, except for four subjects, who could not comply and were tested on a bicycle ergometer. All patients in Sweden and Denmark were tested on a bicycle, which is the customary form for exercise testing in these countries. The variables from the CPET have been described previously [22] . Common heart rate (HR) variables and abbreviations used in this study were: Peak heart rate (HRpeak); Percentage of agepredicted maximum HR (% HRmax) = [(HRpeak/220 age) × 100]; Chronotropic response index (CRI) = (HRpeak HRrest)/(220 age/HRrest); Heart rate reserve (HRreserve ) = HRpeak HRrest; HRrecovery (difference between HRpeak and HR after 30 s, 1, 2, 3 and 4 min).
Secondary endpoints
Potential variables influencing VO2peak, such as lung function, maximum muscle strength and muscular exercise capacity, bioelectrical impedance analysis, echo cardiography, blood samples and HRQoL were measured.
Lung function
Different lung function variables were measured in re lation to the CPET, both at rest and during exercise. Spirometry was performed at rest before CPET: Peak expiratory flow (PEF), forced expiratory volume at 1 min (FEV1), forced vital capacity (FVC) during exercise, maximum ventilation (Vmax) and ventilatory efficiency (VE/VCO2) [14] were calculated.
Muscle strength and muscular exercise capacity
Muscle strength and muscular exercise capacity in the quadriceps and hamstring muscle groups were measured isokinetically. Five repetitions at an angular velocity of 60°/s were performed when measuring muscle maximal strength. For the muscular exercise capacity, 30 isokinetic contractions at 240°/s were performed. In the analyses, we used the bilateral sum of m. quadriceps and m. ham strings [20, 22] .
Bioelectrical impedance analysis
Bioelectrical impedance is a simple and fairly valid method to measure body composition [24] . In this study, the Tanita (Tanita, Arlington Heights, IL, United States) system was used to measure body fat, body water, muscle mass, bone mass, visceral fat, metabolic age and basal metabolic rate.
Echocardiography
Standard Dopplerechocardiography was performed by experienced technicians and assessed by cardiologists to determine myocardial size and function.
Biochemistry
All patients underwent blood sampling in the morning in a fasting state. Two EDTA tubes were collected, inverted ten times and immediately placed on ice. Samples were centrifuged within 20 min. Plasma was transferred into four vials and frozen at 80 ℃. One serum tube was collected and placed in room temperature for 60 to 120 min for coagulation before centrifugation. The sample was then transferred into two vials and frozen at 80 ℃. groupwise in Tables 1 and 2 .
Compared to the highcapacity group, the lowcapa city group was characterized by a higher body mass index (BMI) and a higher fat content, they were more often exsmokers, had lower PCS score, had less muscle strength and muscular exercise capacity, had lower FEV1, FVC and ejection fraction (EF) as measured by echo cardiography. The lowcapacity group more often used beta blockers and less mycophenolate, had higher NT proBNP, hsTnT, triglycerides and lower hemoglobin (Hgb). Duration of heart failure before HTx, primary diagnosis, donor age, ischemic time, rejection scores, MCS score and HADS depression score were similar between the two groups ( Table 1) .
Exercise variables
Exercise variables are shown in Table 2 . As compared with the highcapacity group, the lowcapacity group exercised for a shorter time, had lower maximal venti lation, O2 pulse, HRpeak and HRreserve, while VE/VCO2 slope was higher ( Table 2 ). The respiratory exchange ratio (RER), rated perceived exertion (RPE) and blood pressure responses were similar between the groups ( Table 2 ).
Predictors of VO2peak
Univariate predictors of VO2peak are shown in Tables 1 and  2 . There were strong correlations (P < 0.001) between VO2peak and HRreserve, O2 pulse and muscular exercise capacity (Figures 13). In multiple regression analyses, O2 pulse, HRreserve, muscular exercise capacity, BMI, gender and age accounted for 84% of the variance in VO2peak (L/min). Only O2 pulse, HRreserve and muscular exercise capacity were important determinants in the final model (P < 0.001, P < 0.001 and P < 0.015, respectively). Other potential predictors were also analyzed in the multiple regression analyses, but these did not reach statistical significance. VO2peak (L/min) was chosen as the dependent variable in order to be able to adjust for and see the impact of age, gender and BMI directly, as the VO2peak (mL/kg per min) variable is already weightbased.
Safety
All measurements performed in this study, including the CPET and muscle strength testing, were completed without any minor or serious adverse events.
DISCUSSION
The main findings in this study were that de novo HTx patients display reduced exercise capacity compared with a general population: The reference population in ACSM [27] and Astrand [28] , and that maximal exercise capacity was determined by both central (O2 pulse and HRreserve) and peripheral factors (muscular exercise capa city) (Table 3 and Figures 13) . Furthermore, CPET can be safely performed as early as an average of 11 wk after HTx and is a valuable basis for individual tailoring of the further rehabilitation program.
Plasma concentrations of Nterminal pro brain na triuretic peptide (NTproBNP) was determined using an electrochemiluminescence immunoassay on a Modular platform (Roche Diagnostica, Basel, Switzerland), high sensitive Creactive protein (hsCRP) levels using a particleenhanced, highsensitive immunoturbidimetric assay (hsCRP, TinaQuant CRP Gen.3), and highsensitive troponin T (hsTnT) was measured by electrochemi luminescence immunoassay (hsTnT, Elecsys Troponin T high sensitive, Roche Diagnostics).
HRQoL and symptoms of anxiety and depression
HRQoL was measured with the generic questionnaire short form36, version 2 (SF36v2) [25] . The results were transformed into normbased scores on a standardized scale with a mean of 50 and a standard deviation (SD) of 10 [25] . Subscales were aggregated into two sum scores; physical component summary (PCS) and mental component summary (MCS). Symptoms of anxiety and depression were measured with the Hospital Anxiety and Depression Scale (HADS) [26] . The values were dicho tomized using a cutoff score ≥ 8, which was considered to represent symptoms of depression or anxiety.
Statistical analysis
All data were analyzed using IBM SPSS, version 23 and version 25.0 (IBM corporation, United States). Continuous data are expressed as mean ± SD or median first quartile (Q1), third quartile (Q3), and categorical data are presented as percentages. Patients were divided by the median VO2peak (mL/kg per min) value into a low capacity group (≤ 19.4) and a highcapacity group (> 19.4). Betweengroup comparisons were performed using two independent samples t or Mann Whitney U test. χ 2 or F were used for categorical data, where appropriate. Bivariate relationships were explored and univariate regression analyses were performed with po tential predictors (Tables 1 and 2 ). To identify the degree of association with VO2peak, all relevant variables with P < 0.05 and other potential variables from the univariate analyses of linear regression were selected for further multiple regression analyses. VO2peak (L/min), adjusted for age, sex and BMI, was used as the dependent variable. The final model was built using a series of multiple regression analyses with the enter method (Table 3) . Assumptions were checked for normality and linearity.
RESULTS
Clinical characteristics
The mean ± SD age of the total study population was 49 ± 13 years, and 73% were men. Patients were on average 11.1 ± 1.8 wk after HTx. The mean VO2peak was 20.4 mL/kg per min, which is 56% of expected compared to the reference values described in the 9 th edition of the American College of Sports Medicine's (ACSM) guidelines for exercise testing and exercise prescription [27] . In addition to the main predictors mentioned above, selfreported physical function was also positively asso ciated with VO2peak in this cohort, which is in accordance with an earlier paper from our research team [15] . Similar findings are reported from the general population in the Norwegian HUNT study, in which physical activity level Rolid K et al . Early VO 2peak in de novo HTx recipients was associated with VO2peak [29] . Although both groups in our current study had a lower score on the physical function subscale compared to the norm values described in Ware et al [25] , the highcapacity group had a clinical meaningful and significantly higher score than the lowcapacity group on physical function. The highcapacity group also had higher score on the PCS. On the other hand, there were no differences between the two groups regarding the psychosocial subscales or MCS in SF36v2.
As previously mentioned, only two previous studies exist that describe determinants for VO2peak in de novo HTx recipients [6, 12] . Kitagaki et al [6] found that knee extensor muscle strength and cholinesterase were important predictors for VO2peak 55 d after surgery. Salyer et al [12] found that age was the only predictor of VO2 peak 68 d after HTx, but they did not include muscular exercise capacity or chronotropic variables in their regression analyses. A small study (n = 15) by Oliveira Carvalho et al [30] described that HRreserve, as the only important variable, was associated with VO2peak six months after HTx, while in maintenance HTx recipients, HRreserve was no longer strongly associated with VO2peak. In HRrecovery after exercise, there was an important difference between early and late HTx recipients, suggesting a partial reinnervation in maintenance HTx recipients [30] . However, peripheral factors such as muscular exercise capacity were not measured in Oliveira Carvalho's study [30] . Borelli et al [31] followed HTx recipients for two years and found that both central and peripheral factors contributed to the reduced VO2peak both early (5.3 mo) and late (2 years) after HTx, but that the improvements in VO2peak seen over two years were mostly related to peripheral factors. In the present study, both HRreserve and O2 pulse were independent predictors of VO2peak. The chronotropic re sponses, CRI, %HRmax and HRpeak were, as expected, lower than normal both in the lowcapacity and the high capacity group. However, the highcapacity group had better chronotropic responses than the lowcapacity group (CRI, P = 0.004; %HRmax, P = 0.021, HRpeak, P = 0.001; HRreserve, P < 0.001). HRrecovery was markedly delayed in both groups, with no difference between the groups. Previous studies in maintenance HTx recipients have reported conflicting results whether chronotropic incompetence is associated with a reduced VO2peak or not. Schwaiblmair et al [32] and Kemp et al [33] found a higher VO2peak in patients with a greater HRreserve, com pared to patients with a lower HRreserve. In contrast, Squires et al [34] found no difference in VO2peak between patients with high versus low HRreserve (46 ± 15 vs 33 ± 15). In a previous study by our research group, where maintenance HTx recipients demonstrated a close to normal chronotropic response, HRreserve was not a strong determinant of VO2peak [20] . However, in this current study of de novo HTx recipients, it is ( Figure 1) . The findings described above suggest that as the initially impaired chronotropic responses improve over time, they become less predictive of VO2peak.
O2 pulse derived from CPET is considered a surrogate for stroke volume [14, 35, 36] . In the current study, there was a strong correlation between VO2 peak and O2 pulse ( Figure  2 ). In line with this, the highcapacity group also had a higher O2 pulse (P < 0.001), increased left ventricular EF, as well as lower NT-proBNP and hs-TnT levels, reflecting a better preserved myocardial function compared with the lowcapacity group.
De novo HTx recipients have reduced muscle mass mostly due to inactivity prior to HTx [18] . The highcapacity group had higher muscular exercise capacity (P < 0.001) and muscular strength (P = 0.001) than the lowcapacity group (Figure 3) , and this finding supports the previously described association between muscle function and VO2peak [20] . Comparing the muscle strength values from our previous study on maintenance recipients [20] with the values in this current study, they are not surprisingly much lower in the de novo recipients. As muscular exercise capacity is the only peripheral predictor for VO2 peak in the current study, peripheral factors might be less dominant than central factors in the early phase after HTx. However, from a clinical point of view, resistance training in the early rehabilitation after HTx is of high importance in order to prevent and restore loss of muscle mass and bone density and is likely to contribute to an improved VO2peak level [37] . In the existing literature, VO2peak in de novo HTx patients is reported to range from 9.2 mL/kg per min up to 19.7 mL/kg per min (13 mo after HTx) [212] . One small study of nine patients with left ventricle assist device (LVAD) prior to HTx had a mean VO2peak of 24.6 mL/kg per min 12 wk after HTx, which is higher than what has been reported in other studies and may be explained by the LVAD effect and the patients' relatively high VO2peak before HTx [38] . Except for this study, our cohort's mean VO2peak level of 20.4 mL/kg per min (measured 11 wk post HTx) is higher than what is previously reported in de novo HTx recipients. Compared to an earlier exercise study in maintenance HTx recipients from our center with a median VO2peak value of 27.3 mL/kg per min [20] , this de novo HTx cohort is below this value, but compared to other international studies in maintenance HTx recipients, our current de novo HTx recipients are close to these reported values [18] . This may be partially related to the early and individualized exercise program conducted at our centers, where the patients are attended to daily by a physical therapist from the multidisciplinary HTx team.
Results from a CPET test can be important in many aspects in the early phase after HTx. First of all, a maximal exercise test is of great value to the individual patient in terms of contributing to increased confidence in their new heart and the body's tolerance to highintensity exercise. Secondly, an early CPET is useful for deciding and tailoring the individual exercise programs and for the further rehabilitation, both for monitoring patients' status and prognosis and measuring effect of exercise. In addition to the many gas exchange variables, the CPET also provides other valuable and useful measurements, such as lung function and chronotropic responses. Finally, as we know that measures of physical capacity are strong predictors for longterm survival in HTx recipients [15, 16] , we suggest that such measures should be routinely included both in the early phase after HTx and at yearly controls thereafter. We underscore that the safety aspect is very important when performing a CPET and it should always be supervised by competent and experienced health personnel.
Limitations
Selection bias is a common risk in all voluntary studies, and although our aim was to include every newly trans planted HTx recipient, the recipients had to be medically stable and able to perform a maximal CPET and other physical tests. Thus, as the median VO2peak value in this de novo cohort is comparable to maintenance HTx recipients' VO2peak values, this may be due to a possible selection bias. This is a crosssectional study, based on the baseline data from an ongoing RCT, and no causal relationships should be drawn from such a study design. We present only associations between VO2peak and different possible determinants. A rather small sample size (n = 81) may also imply type 2 errors, but all the performed statistics were carefully checked for underlying assumptions.
In this de novo HTx cohort, the agepredicted mean VO2 peak value was 56% of ageexpected values, which is comparable to previously reported values in maintenance HTx [18] . Predictors for VO2peak in de novo HTx recipients seem to be of both central (O2 pulse and HRreserve) and peripheral (muscular exercise capacity) origin. A CPET and determination of muscular exercise capacity provide important information for patient motivation, rehabilitation and prognosis and thus, measurements for physical function should be considered as routine examinations early after HTx.
HTx. Individualized exercise prescriptions are very important after HTx, and a CPET early after HTx will guide both clinicians and physiotherapists in this vulnerable phase of the rehabilitation process.
Research objectives
The aim of this study was to investigate determinants of early VO2peak and exercise capacity in a cohort of de novo HTx recipients.
Research methods
This study used baseline data from an ongoing randomized controlled trial investigating high-intensity interval training compared to moderate continuous exercise training among de novo HTx recipients, the HITTS study. A cross sectional analysis was performed on the baseline data from the 81 patients included in the study, and all baseline tests were performed an average of 11 wk after surgery. The primary endpoint was VO2peak measured by CPET. Secondary endpoints were lung function, maximum muscle strength and muscular exercise capacity, bioelectrical impedance analysis, echocardiography, blood samples and health-related quality of life.
Research results
The main findings in this study were that de novo HTx patients display reduced exercise capacity compared to a general population, but comparable with maintenance HTx recipients. This de novo HTx cohort demonstrated a median VO2peak level of 19.4 mL/kg per min at 11 ± 1.8 wk post-HTx. Maximal exercise capacity was determined by both central (O2 pulse and HRreserve) and peripheral factors (muscular exercise capacity). The CPET tests were performed without any serious adverse events mean 11 wk after HTx. This is a cross-sectional study, and no causal relationships should be drawn from such a study design. We present only associations between VO2peak and different possible determinants.
Research conclusions
In this de novo HTx cohort, the age-predicted mean VO2 peak value was 56% of age-expected values, which is comparable to previously reported values in maintenance HTx. Predictors for VO2peak in de novo HTx recipients seem to be of both central and peripheral origin.
Research perspectives
A CPET and determination of muscular exercise capacity provide important information for patient motivation, rehabilitation and prognosis and thus, measurements for physical function should be considered as routine examinations early after HTx.
